RecruitingPhase 4NCT05521789

Erector Spinae Block for Thoracic Surgery

Erector Spinae Blocks for Thoracic Surgery


Sponsor

George Washington University

Enrollment

70 participants

Start Date

Jul 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether a nerve block technique called the Erector Spinae Plane Block — where local anesthetic is injected near the spine — improves pain control and reduces the need for opioids after chest surgery (pulmonary resection, i.e., removing part of a lung). **You may be eligible if...** - You are between 18 and 90 years old - You are scheduled for lung surgery to remove part of the lung (pulmonary resection) **You may NOT be eligible if...** - You are having a procedure like pleurodesis or decortication (other chest procedures) - Your surgery is an emergency - You have an allergy to local anesthetic drugs - You had a significant complication during surgery (such as uncontrolled bleeding or conversion to open surgery) - You are having surgery on both lungs at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGESB Thoracic

Erector spinae thoracic block with bupivacaine


Locations(1)

The George Washington University

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05521789


Related Trials